Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ocean Biomedical

0.0622
-0.0047-7.03%
Post-market: 0.06410.0019+3.05%19:58 EDT
Volume:21.29M
Turnover:1.33M
Market Cap:8.21M
PE:-0.06
High:0.0695
Open:0.0695
Low:0.0561
Close:0.0669
Loading ...

Company Profile

Company Name:
Ocean Biomedical
Exchange:
NASDAQ
Establishment Date:
2019
Employees:
- -
Office Location:
55 Claverick Street,Room 325,Providence,Rhode Island,United States
Zip Code:
02903
Fax:
- -
Introduction:
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP. The company is based in Providence, Rhode Island. Ocean Biomedical, Inc. operates as a subsidiary of Poseidon Bio, LLC.

Directors

Name
Position
Chirinjeev Kathuria
Founder, Executive Chairman, Director
Elizabeth Ng
Chief Executive Officer and Director
Jack A. Elias
Director
Jerome Ringo
Director
Jonathan Kurtis
Director
Martin D. Angle
Director
Michael L. Peterson
Director
Michelle Berrey
Director
Suren Ajjarapu
Director
William Owens
Director

Shareholders

Name
Position
Elizabeth Ng
Chief Executive Officer and Director
Gurinder Kalra
Chief Financial Officer
Chirinjeev Kathuria
Founder, Executive Chairman, Director
Daniel Behr
Executive Vice President and Head of External Innovation and Academic Partnerships
Inderjote Kathuria
Chief Strategy Officer
Robert Sweeney
Chief Accounting Officer